Decision Diagnostics Corp. (DECN)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 2.59 Million USD | 21.22% |
| 2019 | 2.14 Million USD | -0.72% |
| 2018 | 2.16 Million USD | -5.86% |
| 2017 | 2.29 Million USD | -20.16% |
| 2016 | 2.87 Million USD | 33.5% |
| 2015 | 2.15 Million USD | 0.0% |
| 2012 | 4.22 Million USD | 8.8% |
| 2011 | 3.88 Million USD | 355.6% |
| 2010 | 852.35 Thousand USD | 28.82% |
| 2009 | 661.66 Thousand USD | -19.33% |
| 2008 | 820.16 Thousand USD | -46.62% |
| 2007 | 1.53 Million USD | -34.18% |
| 2006 | 2.33 Million USD | -40.92% |
| 2005 | 3.95 Million USD | 24.17% |
| 2004 | 3.18 Million USD | 55.14% |
| 2003 | 2.05 Million USD | 6.51% |
| 2002 | 1.92 Million USD | 154.78% |
| 2001 | 755.81 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q2 | 372.08 Thousand USD | -33.81% |
| 2021 Q3 | 606 Thousand USD | 62.87% |
| 2021 Q1 | 562.09 Thousand USD | -34.23% |
| 2020 FY | 2.59 Million USD | 21.22% |
| 2020 Q1 | 805.38 Thousand USD | 117.55% |
| 2020 Q2 | 497.11 Thousand USD | -38.28% |
| 2020 Q3 | 442.79 Thousand USD | -10.93% |
| 2020 Q4 | 854.58 Thousand USD | 93.0% |
| 2019 Q4 | 370.2 Thousand USD | -9.78% |
| 2019 Q3 | 410.35 Thousand USD | -19.15% |
| 2019 FY | 2.14 Million USD | -0.72% |
| 2019 Q2 | 507.54 Thousand USD | -42.14% |
| 2019 Q1 | 877.12 Thousand USD | 41.24% |
| 2018 Q1 | 738.57 Thousand USD | -26.3% |
| 2018 Q4 | 621.03 Thousand USD | -27.99% |
| 2018 FY | 2.16 Million USD | -5.86% |
| 2018 Q2 | 608.16 Thousand USD | -17.66% |
| 2018 Q3 | 862.44 Thousand USD | 41.81% |
| 2017 Q2 | 676.48 Thousand USD | 41.98% |
| 2017 Q1 | 476.48 Thousand USD | 54.88% |
| 2017 FY | 2.29 Million USD | -20.16% |
| 2017 Q4 | 1 Million USD | 17.9% |
| 2017 Q3 | 849.94 Thousand USD | 25.64% |
| 2016 Q3 | 1.28 Million USD | 4328.71% |
| 2016 FY | 2.87 Million USD | 33.5% |
| 2016 Q4 | 307.65 Thousand USD | -76.01% |
| 2016 Q2 | 28.95 Thousand USD | -98.08% |
| 2016 Q1 | 1.51 Million USD | 158.13% |
| 2015 Q2 | 491 Thousand USD | -70.1% |
| 2015 Q4 | 585.34 Thousand USD | 126.91% |
| 2015 Q3 | 257.96 Thousand USD | -47.46% |
| 2015 Q1 | 1.64 Million USD | 0.0% |
| 2015 FY | 2.15 Million USD | 0.0% |
| 2014 Q2 | 310.57 Thousand USD | -37.01% |
| 2014 Q1 | 493.04 Thousand USD | 0.0% |
| 2013 Q3 | 447.49 Thousand USD | -58.46% |
| 2013 Q2 | 1.07 Million USD | 55.73% |
| 2013 Q1 | 691.73 Thousand USD | -63.6% |
| 2012 Q4 | 1.9 Million USD | 177.35% |
| 2012 Q2 | 1.16 Million USD | 146.09% |
| 2012 Q3 | 685.26 Thousand USD | -41.21% |
| 2012 Q1 | 473.65 Thousand USD | -76.13% |
| 2012 FY | 4.22 Million USD | 8.8% |
| 2011 Q4 | 1.98 Million USD | 70.33% |
| 2011 Q2 | 359.52 Thousand USD | -4.42% |
| 2011 Q1 | 376.15 Thousand USD | 56.85% |
| 2011 FY | 3.88 Million USD | 355.6% |
| 2011 Q3 | 1.16 Million USD | 223.99% |
| 2010 Q2 | 214.42 Thousand USD | 16.3% |
| 2010 Q3 | 213.74 Thousand USD | -0.32% |
| 2010 FY | 852.35 Thousand USD | 28.82% |
| 2010 Q4 | 239.82 Thousand USD | 12.21% |
| 2010 Q1 | 184.37 Thousand USD | 0.02% |
| 2009 Q2 | 235.14 Thousand USD | 152.38% |
| 2009 Q3 | 149 Thousand USD | -36.63% |
| 2009 Q4 | 184.34 Thousand USD | 23.72% |
| 2009 FY | 661.66 Thousand USD | -19.33% |
| 2009 Q1 | 93.16 Thousand USD | -41.9% |
| 2008 Q2 | 204.11 Thousand USD | -32.18% |
| 2008 Q4 | 160.36 Thousand USD | 3.66% |
| 2008 Q3 | 154.7 Thousand USD | -24.21% |
| 2008 Q1 | 300.97 Thousand USD | -28.56% |
| 2008 FY | 820.16 Thousand USD | -46.62% |
| 2007 Q4 | 421.29 Thousand USD | 16.36% |
| 2007 Q3 | 362.07 Thousand USD | 19.63% |
| 2007 Q2 | 302.67 Thousand USD | -32.79% |
| 2007 Q1 | 450.31 Thousand USD | -32.94% |
| 2007 FY | 1.53 Million USD | -34.18% |
| 2006 Q2 | 552.25 Thousand USD | 2.26% |
| 2006 Q3 | 570.26 Thousand USD | 3.26% |
| 2006 Q4 | 671.54 Thousand USD | 17.76% |
| 2006 FY | 2.33 Million USD | -40.92% |
| 2006 Q1 | 540.06 Thousand USD | -65.25% |
| 2005 Q1 | 1.19 Million USD | 318.88% |
| 2005 Q2 | 422.57 Thousand USD | -64.65% |
| 2005 Q4 | 1.55 Million USD | 202.32% |
| 2005 Q3 | 514.13 Thousand USD | 21.67% |
| 2005 FY | 3.95 Million USD | 24.17% |
| 2004 FY | 3.18 Million USD | 55.14% |
| 2004 Q3 | 795.4 Thousand USD | -19.69% |
| 2004 Q2 | 990.4 Thousand USD | -8.1% |
| 2004 Q1 | 1.07 Million USD | 13.85% |
| 2004 Q4 | 285.35 Thousand USD | -64.12% |
| 2003 Q3 | 328.8 Thousand USD | -0.44% |
| 2003 Q1 | 396.7 Thousand USD | -55.7% |
| 2003 Q2 | 330.25 Thousand USD | -16.75% |
| 2003 FY | 2.05 Million USD | 6.51% |
| 2003 Q4 | 946.56 Thousand USD | 187.88% |
| 2002 Q2 | 293.72 Thousand USD | -1.34% |
| 2002 Q4 | 895.5 Thousand USD | 105.18% |
| 2002 Q3 | 436.44 Thousand USD | 48.59% |
| 2002 FY | 1.92 Million USD | 154.78% |
| 2002 Q1 | 297.71 Thousand USD | 0.0% |
| 2001 FY | 755.81 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 3437.19 USD | 100.0% |
| Allstar Health Brands, Inc. | 215.74 Thousand USD | 100.0% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 55.24 Million USD | 100.0% |
| Café Serendipity Holdings, Inc. | 1.43 Million USD | 100.0% |
| Health Advance Inc. | 47.57 Thousand USD | 100.0% |
| HealthWarehouse.com, Inc. | 13.79 Million USD | 100.0% |
| LIGAND PHARMACEUTICAL INC | 78.2 Million USD | 100.0% |
| MedGen, Inc. | 16.59 USD | 100.0% |
| Omni Health, Inc. | 1.14 Million USD | 100.0% |
| Oxford Investments Holdings Inc. | 373.76 Thousand USD | 100.0% |
| Pineapple, Inc. | 452.94 Thousand USD | 100.0% |
| ScripsAmerica, Inc. | 31.4 Million USD | 100.0% |